These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15299084)

  • 1. Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.
    Klopper JP; Hays WR; Sharma V; Baumbusch MA; Hershman JM; Haugen BR
    Mol Cancer Ther; 2004 Aug; 3(8):1011-20. PubMed ID: 15299084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression.
    Klopper JP; Sharma V; Berenz A; Hays WR; Loi M; Pugazhenthi U; Said S; Haugen BR
    Mol Cancer; 2009 Mar; 8():16. PubMed ID: 19267912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
    Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
    J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells.
    Chen JY; Wang JJ; Lee HC; Chi CW; Lee CH; Hsu YC
    J Chin Med Assoc; 2020 Oct; 83(10):923-930. PubMed ID: 33009242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
    Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
    Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
    Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M
    Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
    Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
    Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
    Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
    Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
    Papi A; Rocchi P; Ferreri AM; Orlandi M
    Cancer Lett; 2010 Nov; 297(1):65-74. PubMed ID: 20510503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.
    Copland JA; Marlow LA; Kurakata S; Fujiwara K; Wong AK; Kreinest PA; Williams SF; Haugen BR; Klopper JP; Smallridge RC
    Oncogene; 2006 Apr; 25(16):2304-17. PubMed ID: 16331265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
    Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
    Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model.
    Shimazaki N; Togashi N; Hanai M; Isoyama T; Wada K; Fujita T; Fujiwara K; Kurakata S
    Eur J Cancer; 2008 Aug; 44(12):1734-43. PubMed ID: 18511262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
    Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
    Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
    Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT
    J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.